BRISTOL, England, January 7 /PRNewswire/ -- If you can dream it, you can build it as Majesco Entertainment Company (NASDAQ: COOL), an innovative provider of video games for the mass market, today announced Our House for the Wii(TM) home video game system. Developed by Budcat Creations, Our House turns the Wii Remote(TM) into the ultimate creation tool that lets players design, build and decorate their own personalized trophy home they can share with others in an online neighborhood.

MILPITAS, California, January 7 /PRNewswire/ --

- Innovative ESD Architecture and New Website Launched

LAS VEGAS, CES 2008, January 7 /PRNewswire/ --

- Turnkey Hardware/Software Solution with Award-Winning Video Processing Enables Rapid Time-to-Market of Richly Featured LCD-TVs

Marvell (Nasdaq: MRVL), a leader in storage, communications, and consumer silicon solutions, today announced the 88DE2710-WX, a complete HD-ready hardware and software solution LCD-TV chassis. Featuring the Marvell(R) 88DE2710 digital video format converter with Qdeo(TM) video processing, the 88DE2710-WX reference design delivers consistent, immersive viewing experiences with all types of content and video sources.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070905/AQW167LOGO )

PRINCETON, New Jersey, January 7 /PRNewswire/ --

- 85% of patients achieve undetectable HCV RNA levels following 4 weeks of treatment with R7128 1500mg and Pegasys(R) plus Copegus(R) with safety and tolerability comparable to placebo -

- Conference Call Scheduled for 4:00PM ET Today -

LAS VEGAS, CES, January 7 /PRNewswire/ --

- Marvell 88DE2710 Digital Video Format Converter Powers Premium Quality Video on LCD Televisions

Marvell (Nasdaq: MRVL) today announced that its award-winning Qdeo(TM) video processing is a featured technology of the Onida 42" Xaria LCD-TV, developed for the emerging markets of India and the Gulf countries. Part of the Marvell(R) 88DE2710 digital video format converter, Qdeo delivers quiet, natural video free of artifacts and noise, enhances the color, and intelligently scales all video inputs into a high-definition format.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070905/AQW167LOGO)

BASEL, Switzerland, January 7 /PRNewswire/ --

- For non US or non UK Media Only

- Oral Chemotherapy Tablet Option Reduces the Time Patients Need to Spend in the Hospital

Data recently published in the New England Journal of Medicine confirm oral chemotherapy tablet Xeloda (capecitabine) as a first-line treatment for advanced stomach cancer. The publication reinforces the drug's use for this difficult-to-treat disease, enabling clinicians to prescribe Xeloda in combination with platinum-based chemotherapy. Stomach cancer is the fourth most commonly diagnosed cancer and the second leading cause of cancer-related deaths worldwide(1.). Annually, there are an estimated 911,000 deaths worldwide(2.), with nearly 140,000 deaths in Europe alone(3.).